» Articles » PMID: 32625944

Guidance for the Identification of Endocrine Disruptors in the Context of Regulations (EU) No 528/2012 and (EC) No 1107/2009

Abstract

This Guidance describes how to perform hazard identification for endocrine-disrupting properties by following the scientific criteria which are outlined in Commission Delegated Regulation (EU) 2017/2100 and Commission Regulation (EU) 2018/605 for biocidal products and plant protection products, respectively.

Citing Articles

Peer review of the pesticide risk assessment of the active substance maltodextrin.

Alvarez F, Arena M, Auteri D, Batista Leite S, Binaglia M, Castoldi A EFSA J. 2025; 23(3):e9294.

PMID: 40071031 PMC: 11894470. DOI: 10.2903/j.efsa.2025.9294.


Peer review of the pesticide risk assessment of the active substance pyraclostrobin.

Alvarez F, Arena M, Auteri D, Batista Leite S, Binaglia M, Castoldi A EFSA J. 2025; 23(3):e9257.

PMID: 40051450 PMC: 11883416. DOI: 10.2903/j.efsa.2025.9257.


Evaluation of the endocrine disrupting potential of Di-isodecyl phthalate.

Lea I, Feifarek D, Mihalchik A, Heintz M, Haws L, Nyambego H Curr Res Toxicol. 2025; 8:100221.

PMID: 40041033 PMC: 11879679. DOI: 10.1016/j.crtox.2025.100221.


Peer review of the pesticide risk assessment of the active substance daminozide.

Alvarez F, Arena M, Auteri D, Batista Leite S, Binaglia M, Castoldi A EFSA J. 2025; 23(2):e9210.

PMID: 39989887 PMC: 11843222. DOI: 10.2903/j.efsa.2025.9210.


Peer review of the pesticide risk assessment of the active substance clomazone.

Alvarez F, Arena M, Auteri D, Batista Leite S, Binaglia M, Castoldi A EFSA J. 2025; 23(2):e9206.

PMID: 39989885 PMC: 11843221. DOI: 10.2903/j.efsa.2025.9206.


References
1.
Ankley G, Jensen K . A novel framework for interpretation of data from the fish short-term reproduction assay (FSTRA) for the detection of endocrine-disrupting chemicals. Environ Toxicol Chem. 2014; 33(11):2529-40. DOI: 10.1002/etc.2708. View

2.
Dimitrov S, Diderich R, Sobanski T, Pavlov T, Chankov G, Chapkanov A . QSAR Toolbox - workflow and major functionalities. SAR QSAR Environ Res. 2016; 27(3):203-219. DOI: 10.1080/1062936X.2015.1136680. View

3.
Cutolo M, Seriolo B, Villaggio B, Pizzorni C, Craviotto C, Sulli A . Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann N Y Acad Sci. 2002; 966:131-42. DOI: 10.1111/j.1749-6632.2002.tb04210.x. View

4.
Vermeire T, Aldenberg T, Buist H, Escher S, Mangelsdorf I, Paune E . OSIRIS, a quest for proof of principle for integrated testing strategies of chemicals for four human health endpoints. Regul Toxicol Pharmacol. 2013; 67(2):136-45. DOI: 10.1016/j.yrtph.2013.01.007. View

5.
Beausoleil C, Ormsby J, Gies A, Hass U, Heindel J, Holmer M . Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary. Chemosphere. 2013; 93(6):847-56. DOI: 10.1016/j.chemosphere.2013.06.043. View